Decarboxylases

These factors can be classified into the following groups: (1) pre-treatment (baseline) individual characteristics, such as complex karyotypes or adverse genes, high pre-infusion MRD by flow cytometry in the bone marrow, high pre-lymphodepletion LDH, and low pre-lymphodepletion platelet count; (2) lymphodepletion routine without fludarabine; (3) post-CAR T-cell infusion guidelines, such as persistent leukemic cells in the bone marrow and early loss of CAR T-cells

These factors can be classified into the following groups: (1) pre-treatment (baseline) individual characteristics, such as complex karyotypes or adverse genes, high pre-infusion MRD by flow...